SULT1E1 | Sulfotransferase family 1E, estrogen-preferring, member 1 | Cancer-related genes Enzymes
| | | | | Group enriched |
TTC36 | Tetratricopeptide repeat domain 36 | | | | | | Tissue enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
ANGPTL3 | Angiopoietin-like 3 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFB | Complement factor B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CNDP1 | Carnosine dipeptidase 1 (metallopeptidase M20 family) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CYP2C9 | Cytochrome P450, family 2, subfamily C, polypeptide 9 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
EHHADH | Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
RGN | Regucalcin | Enzymes Plasma proteins
| | | | | Group enriched |
SARDH | Sarcosine dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted membrane proteins
| | | | | Group enriched |
FABP1 | Fatty acid binding protein 1, liver | Cancer-related genes Plasma proteins
| | | | | Group enriched |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
GNMT | Glycine N-methyltransferase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
IGFBP1 | Insulin-like growth factor binding protein 1 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Group enriched |
PLG | Plasminogen | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINA3 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC27A2 | Solute carrier family 27 (fatty acid transporter), member 2 | Enzymes Predicted membrane proteins Transporters
| | | | | Group enriched |
SORD | Sorbitol dehydrogenase | Enzymes Plasma proteins
| | | | | Group enriched |
TTR | Transthyretin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACSM5 | Acyl-CoA synthetase medium-chain family member 5 | Enzymes Mitochondrial proteins
| | | | | Tissue enriched |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
C3 | Complement component 3 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C4BPA | Complement component 4 binding protein, alpha | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
NADK2 | NAD kinase 2, mitochondrial | Enzymes
| | | | | Tissue enriched |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SULT1A2 | Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 | Enzymes
| | | | | Group enriched |
A1CF | APOBEC1 complementation factor | | | | | | Tissue enhanced |
AADAT | Aminoadipate aminotransferase | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
ACOX2 | Acyl-CoA oxidase 2, branched chain | Enzymes
| | | | | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CDO1 | Cysteine dioxygenase type 1 | Enzymes
| | | | | Tissue enhanced |
CFH | Complement factor H | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN1 | Claudin 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CTH | Cystathionase (cystathionine gamma-lyase) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CYP4F11 | Cytochrome P450, family 4, subfamily F, polypeptide 11 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP4F3 | Cytochrome P450, family 4, subfamily F, polypeptide 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |